{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2001"],"condition":["Secondary","Colorectal Neoplasms","Drug Therapy, Combination"],"disease":["Secondary","Colorectal Neoplasms","Drug Therapy, Combination"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2042450"],"location":["South Korea"],"study_start_month":["11"],"keyword":["Irinotecan","Capecitabine"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer","description":"This study is to evaluate the efficacy and safety of combination chemotherapy with irinotecan and capecitabine in previously untreated metastatic colorectal cancer.","dates":{"creation":"2001-11-15"},"accession":"2042450","cross_references":{"ClinicalTrials___gov":["NCT00506168"]}}